Allspring Global Investments’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Allspring Global Investments's BMY Position: Q1 2026 in Review
Allspring Global Investments increased its Bristol-Myers Squibb (BMY) stake by 5.5% in Q1 2026, buying an estimated $3.34M and bringing the position to 1,095,654 shares worth $67.6M. The position accounts for 0.11% of the portfolio, ranked #214.
Allspring Global Investments first reported a position in BMY in Q4 2021 and has held it in 18 quarters since. The position peaked at $151M in Q4 2021. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Allspring Global Investments held 1,095,654 shares of Bristol-Myers Squibb worth $67.6M as of Q1 2026.
- Allspring Global Investments bought 57,224 Bristol-Myers Squibb shares in Q1 2026, an estimated $3.34M.
- Bristol-Myers Squibb made up 0.11% of Allspring Global Investments's portfolio in Q1 2026, its #214 holding.
- Allspring Global Investments first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 18 quarters since.
- Allspring Global Investments's Bristol-Myers Squibb position peaked at $151M in Q4 2021.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.